Concepedia

Jonathan Li

JL

Statistics

Publications

10

Citations

374

H-Index

10

Active since

2008

Affiliations

University of California, San Francisco(Current)

UNSW Sydney

South Texas Accelerated Research Therapeutics

Sarah Cannon

BioVirtus (Poland)

Jonathan Li is an author at University of California, San Francisco specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2008–2024

10

Publications

10

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

Jason J. Luke, Manish R. Patel, George R. Blumenschein et al. · Nature Medicine · 2023 · 128 citations · Full text

, , +17

A pilot study to assess the safety and efficacy of the Third Eye retrograde auxiliary imaging system during colonoscopy

George Triadafilopoulos, Jonathan Li · Endoscopy · 2008 · 54 citations

, , +14

Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule

Alexey Berezhnoy, Bradley Sumrow, Kurt Stahl et al. · Cell Reports Medicine · 2020 · 53 citations · Full text

, , +17

Prevalence and Onset of Pediatric Sickle Cell Retinopathy.

Jonathan Li, Lloyd Bender, James Shaffer et al. · PubMed · 2019 · 30 citations

, , +11

Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma

Pamela Boimel, Abigail T. Berman, Jonathan Li et al. · Journal of Gastrointestinal Oncology · 2017 · 27 citations · Full text

, , +17

1–5 of 10